| Literature DB >> 34527310 |
Sabina Isabel Lähteenmäki1,2, Thanos Sioris2, Heidi S S Mahrberg2, Irina C Rinta-Kiikka3, Jari O Laurikka1,2.
Abstract
BACKGROUND: Two respiratory physiotherapy modalities were compared in a randomized controlled trial on patients undergoing minor pleuro-pulmonary surgery.Entities:
Keywords: Minor lung resection; inspiratory muscle training (IMT); positive expiratory pressure training (PEP training); pulmonary function; respiratory physiotherapy
Year: 2021 PMID: 34527310 PMCID: PMC8411129 DOI: 10.21037/jtd-21-473
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Participant flow chart.
Main patient parameters in the study groups
| Characteristics | PEP group (n=23) | IMT group (n=22) | P value |
|---|---|---|---|
| Age, years, mean (SD) | 58 (15.0) | 59 (11.0) | 0.40 |
| BMI, mean (SD) | 27.6 (5.5) | 28.7 (7.0) | 0.40 |
| Sex, n (%) | 0.88 | ||
| Male | 12 (52.2) | 11 (50.0) | |
| Female | 11 (47.8) | 11 (50.0) | |
| Smoking history | 0.47 | ||
| Current smoker | 6 | 7 | |
| Ex-smoker | 9 | 4 | |
| Lifetime non-smoker | 7 | 10 | |
| Pre-operative ventilation function, n (%) | 0.58 | ||
| Normal | 7 (30.4) | 5 (22.7) | |
| Mildly decreased | 7 (30.4) | 10 (45.5) | |
| Moderately decreased | 8 (34.8) | 5 (22.7) | |
| Severely decreased | 1 (4.3) | 2 (9.1) | |
| Pre-operative SpO2, mean (SD) | 96.3 (1.5) | 95.8 (1.8) | 0.29 |
| Main diagnosis, n (%) | 0.51 | ||
| Primary lung cancer | 2 (8.7) | 6 (27.3) | |
| Lung metastasis | 7 (30.4) | 3 (13.6) | |
| Benign tumor | 5 (21.7) | 3 (13.6) | |
| Pleural fluid | 1 (4.3) | 1 (4.5) | |
| Pneumothorax | 1 (4.3) | 1 (4.5) | |
| Un-defined lung tumor or abnormal imaging of the lung | 7 (30.4) | 8 (36.3) | |
| Co-morbidities, n (%) | |||
| COPD | 5 (21.7) | 2 (9.1) | 0.24 |
| Asthma | 0 (0) | 2 (9.1) | 0.14 |
| Asbestosis | 3 (13.0) | 1 (4.5) | 0.32 |
| Coronary artery disease | 2 (8.7) | 0 (0) | 0.16 |
| Hypertension | 8 (34.8) | 10 (45.5) | 0.47 |
| Type II diabetes | 3 (13.0) | 2 (9.1) | 0.67 |
| Congestive heart disease | 0 (0) | 0 (0) | |
| Type of surgery, n (%) | 0.60 | ||
| Thoracotomy | 9 (39.1) | 5 (22.7) | |
| Biopsy | 3 (13.0) | 1 (4.5) | |
| Tumor excision | 4 (17.4) | 2 (9) | |
| Wedge resection | 1 (4.3) | 2 (9.1) | |
| Pleurectomy | 1 (4.3) | 0 (0) | |
| VATS, n (%) | 14 (60.9) | 17 (77.3) | |
| Biopsy | 8 (34.8) | 6 (27.3) | |
| Tumor excision | 3 (13.0) | 7 (31.8) | |
| Wedge resection | 3 (13.0) | 4 (18.2) |
Current smoker: smoking till date of surgery. Ex-smoker: abstained for minimum of two weeks prior to surgery. Non-smoker: has never smoked. Normal: FEV1 80–126%; mildly decreased: FEV1 65–79%; moderately decreased: FEV1 45–64%; severely decreased FEV1 25–44%. COPD, chronic obstructive pulmonary disease; VATS, video assisted thoracic surgery; PEP, positive expiratory pressure; IMT, inspiratory muscle training.
Pre- and post-operative pulmonary function values in the study groups
| Variable (SD) | PEP | Preop | IMT | Preop | Between groups PEP | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preop | 1POD | 2POD | P value | Preop | 1POD | 2POD | P value | F-statistic (P value) | |||||
| FVC, L/sec | 3.51 (1.07) | 2.46 (1.76) | 2.84 (1.35) | P<0.001, P=0,076 | 3.31 (1.11) | 2.34 (0.87) | 3.03 (1.17) | p<0.001, P=0,002 | 0.072 (0.890) | ||||
| FVC% | 87.96 (24.16) | 56.39 (18.84) | 63.05 (21.10) | P<0.001, P=0.003 | 81.55 (17.18) | 59.50 (18.70) | 66.18 (18.85) | P<0.001, P=0.001 | 0.004 (0.947) | ||||
| FEV1, L/sec | 2.68 (0.89) | 1.66 (0.63) | 1.86 (0.71) | P<0.001, P=0.023 | 2.50 (0.86) | 1.79 (0.66) | 2.03 (0.73) | P<0.001, P=0.006 | 0.042 (0.838) | ||||
| FEV1% | 84.14 (28.79) | 51.68 (17.76) | 58.05 (19.97) | P<0.001, P=0.004 | 77.86 (18.50) | 56.68 (19.02) | 63.55 (18.70) | P<0.001, P=0.002 | 0.065 (0.800) | ||||
| PEF, L/sec | 6.97 (2.30) | 4.16 (1.78) | 4.59 (1.86) | P<0.001, P=0.021 | 6.59 (1.80) | 4.49 (1.72) | 5.23 (1.69) | P<0.001, P<0.001 | 0.152 (0.698) | ||||
| PEF% | 83.77 (32.56) | 48.73 (17.97) | 53.86 (19.00) | P<0.001, P=0.020 | 78.77 (16.37) | 53.91 (18.54) | 62.77 (17.72) | P<0.001, P<0.001 | 0.318 (0.576) | ||||
| PIF, L/sec | 5.97 (1.91) | 3.96 (1.52) | 3.96 (1.63) | P<0.001, P=0.989 | 5.55 (1.88) | 3.71 (1.38) | 4.11 (1.77) | P<0.001, P=0.053 | 0.137 (0.713) | ||||
| PIF% | 93.05 (26.17) | 60.45 (19.44) | 60.36 (20.23) | P<0.001, P=0.978 | 87.05 (24.88) | 58.91 (20.34) | 65.18 (25.42) | P<0.001, P=0.066 | 0.024 (0.878) | ||||
| FIVC, L/sec | 3.67 (1.09) | 2.45 (1.00) | 2.69 (1.09) | P<0.001, P=0.019 | 3.42 (1.03) | 2.48 (0.82) | 2.79 (0.99) | P<0.001, P=0.003 | 0.023 (0.880) | ||||
| FIV1, L/sec | 3.56 (1.08) | 2.17 (0.88) | 2.49 (0.95) | P<0.001, P=0.002 | 3.35 (1.02) | 2.32 (0.79) | 2.62 (0.90) | P<0.001, P=0.003 | 0.008 (0.929) | ||||
| MIP, cmH2O | 84.55 (34.40) | – | 61.23 (23.92) | N.A., P<0.001 | 77.36 (26.74) | – | 60.77 (22.48) | N.A., P=0.005 | (0.402) | ||||
FVC forced vital capacity: the determination of the vital capacity from a maximally forced expiratory effort; L/sec, litres per second; SD, standard deviation; FVC%, forced vital capacity in proportion to control populations results; FEV1, forced expiratory volume during one second; FEV1%, forced expiratory volume during one second in proportion to control populations results; PEF, peak expiratory flow; PEF%, peak expiratory flow in proportion to control populations results; PIF, peak inspiratory flow; PIF%, peak inspiratory flow in proportion to control populations results; FIVC, forced inspiratory vital capacity; FIV1, forced inspiratory volume during one second; MIP, maximal inspiratory pressure. Preop, values on day before surgery; 1POD, first postoperative day; 2POD, second postoperative day.
Postoperative pulmonary function test values in proportion to preoperative value (mean ratio, with SD) in intervention groups
| Variable | PEP | IMT | P value | |||
|---|---|---|---|---|---|---|
| 1POD/preop (SD) | 2POD/preop (SD) | 1POD/preop (SD) | 2POD/preop (SD) | |||
| FVC | 0.69 (0.32) | 0.72 (0.20) | 0.72 (0.18) | 0.80 (0.15) | 0.38 | |
| FEV1 | 0.64 (0.19) | 0.70 (0.17) | 0.74 (0.20) | 0.82 (0.16) | 0.045 | |
| PEF | 0.61 (0.20) | 0.67 (0.19) | 0.69 (0.21) | 0.80 (0.17) | 0.051 | |
| PIF | 0.68 (0.05) | 0.68 (0.05) | 0.70 (0.25) | 0.76 (0.26)) | 0.407 | |
| FIVC | 0.67 (0.19) | 0.73 (0.15) | 0.74 (0.17) | 0.82 (0.17) | 0.098 | |
| FIV1 | 0.62 (0.18) | 0.70 (0.15) | 0.71 (0.18) | 0.79 (0.16) | 0.060 | |
1POD/preop, first postoperative day value in proportion to pre-operative value; 2POD/preop, second postoperative day value in proportion to pre-operative value.
Figure 2Relative values of FEV1 at different measurement dates in proportion to preoperative day value. Blue line illustrates water bottle PEP group and red line illustrates inspiratory muscle training (IMT) group.
Figure 3Relative values of FIV1 at different measurement dates in proportion to preoperative day value. Blue line illustrates water bottle PEP group and red line illustrates inspiratory muscle training (IMT) group.
Patient-reported NRS-score for postoperative pain in intervention groups
| NRSa | 1PODb | 2PODc | |||
|---|---|---|---|---|---|
| PEP | IMT | PEP | IMT | ||
| 0 | 1 | 5 | 4 | 11 | |
| 1 | 0 | 6 | 7 | 2 | |
| 2 | 8 | 3 | 4 | 4 | |
| 3 | 2 | 5 | 2 | 2 | |
| 4 | 4 | 0 | 1 | 0 | |
| 5 | 4 | 1 | 3 | 2 | |
| 6 | 1 | 1 | 0 | 0 | |
| 7 | 2 | 0 | 1 | 0 | |
| 8 | 1 | 1 | 1 | 1 | |
| 9 | 0 | 0 | 0 | 0 | |
| 10 | 0 | 0 | 0 | 0 | |
| (P=0.010) | (P=0.313) | ||||
NRS, numerical reference scale; 1POD, first postoperative day; 2POD, second postoperative day.
Mean postoperative walking distances of the intervention groups on the first and the second postoperative day
| Variable | PEP | IMT | P value | |||
|---|---|---|---|---|---|---|
| 1POD | 2POD | 1POD | 2POD | |||
| Walking distance, meters (SD) | 390.4 (195.7) | 720.4 (332.7) | 396.8 (283.6) | 721.0 (421.5) | 0.97 | |
| Range, meters in 24 hours | 100–800 | 140–1,450 | 0–900 | 2–1,500 | ||
1POD, first postoperative day; 2POD, second postoperative day.